Skip to main content
ABBOTT LABORATORIES logo

ABBOTT LABORATORIES — Investor Relations & Filings

Ticker · ABT ISIN · US0028241000 LEI · HQD377W2YR662HK5JX27 US Manufacturing
Open in API
Filings indexed 4,256 across all filing types
Latest filing 2017-01-04 Director's Dealing
Country US United States of America
Listing US ABT

About ABBOTT LABORATORIES

https://www.abbott.com

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.

Recent filings

Filing Released Lang Actions
FORM 4 -
Director's Dealing
2017-01-04 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 registration statement filed with the SEC, which is used to register securities to be offered to employees under employee benefit plans. It includes detailed information about the securities, the plan under which they are offered, indemnification provisions, and exhibits. It is not an annual report, earnings release, or any other financial report but a registration statement related to employee compensation plans. Therefore, it fits the category of a regulatory filing that does not fall into other specific categories.
2017-01-04 English
S-8 POS
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 on Form S-8 filed with the SEC by Abbott Laboratories. It relates to the registration of shares issuable under stock incentive plans following a merger acquisition. The document is a registration statement amendment concerning securities issuance and stock plans, specifically referencing Form S-8 and Form S-4 filings. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and amendments thereof. Therefore, it fits best under Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing.
2017-01-04 English
SC 13G
Major Shareholding Notification
2016-12-30 English
425 Filing
M&A Activity Classification · 95% confidence The document is a news release announcing Abbott Laboratories' acquisition of St. Jude Medical, Inc. It includes details about the transaction, strategic fit, product pipeline, expected financial impact, and regulatory clearances. The document references a Form S-4 registration statement and a proxy statement/prospectus related to the transaction, but it is not itself a merger proxy statement or a merger filing. It is a public announcement of a merger closing date and related information. The document is not a full financial report, audit report, or earnings release. It is not a regulatory filing or certification. It is a transaction announcement related to a merger/acquisition. The document is about the merger transaction and its strategic and financial implications, fitting the category of M&A Activity (TAR). The length (9793 characters) and content confirm it is a detailed announcement rather than a brief notice or a proxy solicitation. Therefore, the best classification is M&A Activity (TAR).
2016-12-30 English
FORM 4 -
Director's Dealing
2016-12-21 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.